Science Corp Raises $230 Million In Series C Round At $1.5 Billion Valuation

Science Corp., founded by former Neuralink president Max Hodak, has raised $230 million in a Series C round at a reported $1.5 billion post-money valuation to advance commercialization of its PRIMA brain-implant technology and expand its broader research programs. The company is focused on bringing its implant — designed to restore functional vision for patients with advanced macular degeneration — toward regulatory approval in Europe while scaling additional initiatives such as its biohybrid neural interface and the Vessel organ-preservation platform. Investors in the round include Lightspeed Venture Partners, Khosla Ventures, Y Combinator, Quiet Capital, and IQT, bringing total funding to $490 million.

FOUNDER: Max Hodak

INVESTORS: Lightspeed Venture Partners, Khosla Ventures, Y Combinator, Quiet Capital & IQT

ROUND: Series C AMOUNT: $230,000,000 VALUATION: $1,500,000,000

HQ: Alameda, California

#VentureCapital #ScienceCorp #MaxHodak #TradedVC